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Abstract
Intensity modulated proton therapy (IMPT) provides highly conformal dose distributions through the application
of multiple, angularly spaced fields, each applying an ad-hoc pattern of spatially varying particle fluences. In partic-
ular, Bragg peaks are simultaneously optimized for all the fields. Once the number and the direction of the fields are
set, the dose distribution of the IMPT plan is determined by the dose constraints assigned to specific organs-at-risk
(OARs) surrounding the tumour.
In this work, we introduce a new feature for the OARs, called opacity, aimed at improving the quality and the robust-
ness of IMPT plans, by modifying, in the pre-optimization stage, the fluence of the pencil beams, that intersect those
structures. The proposed IMPT planning strategy is addressed to those clinical cases, where metallic prothesis or fast
density-varying organs can compromise the stability of the dose distribution. We show how the usage of this additional
parameter can lead to more accurate IMPT plans with respect to the situation in which only dose constraints are
adopted.
Keywords: Proton therapy, IMPT, dose constraints, pencil beam modulation, Siddon algorithm, robustness, metal
implants, fast varying cavities.
1 Proposed method
1.1 Pencil beam based treatment
Treatment plans usually involve more the one proton field in order to guarantee dose homogeneity over the target volume
and to increase the stability of the plan. The active scanning technique [1] allows, in particular, to control the dose
deposition of each focused pencil beam within the patient volume; this implies that a field is conceived as the collection
of all the single dose spots delivered for a specific position of the patient with respect to the nozzle. Thank to this
peculiarity, the active scanning enables the construction of complex-shaped dose distributions. Once the number and
direction of the proton fields are selected for a treatment, there are two different planning strategies implemented for active
scanning based gantries: single field uniform dose (SFUD) [2], implying a superposition of the individually optimized
dose distributions; intensity modulated proton therapy (IMPT) [3], consisting in a simultaneous optimization of all the
fields. The latter modality can often provide better tradeoffs between the dose coverage of the target and the sparing of
the organs at risk.
1.2 IMPT optimization
The IMPT optimization consists in the following problem [4]:
ω = argmin
ω
F (ω) (1)
F (ω) =
∑
it
(Pit −Dit(ω))2 +
∑
io
g2io (Pio −Dio(ω))2 (2)
where the first sum runs on the voxel indices of the target {it} and the second one on the voxel indices of the OARs {io},
Pj and Dj are respectively the prescribed and the computed dose for the j-th voxel, {gio}’s are weights chosen by the
planner and ω = {ω1, · · · , ωN} corresponds to the fluences of the pencil beams. The iterative minimizer of (2) is with
the OAR dose constraints, applied through the weights {gio} and with ω(0), such that each field is characterized by a
flat spread-out bragg peak (SOBP) [5] within the target volume. Since the number and direction of the fields have been
already fixed and the pre-optimized fluences ω(0) are automatically computed on the basis of the target volume, the dose
constraints are the only leverage left at disposal of the planner to modify the resulting dose distribution.
1.3 Opacity concept
The opacity is defined as a quality of the OARs in relation to the pencil beams and has to be considered as a simple
weight ranging in [0,1]. The opacity level (OL) of an OAR is thought to modify the pre-optimized fluences ω(0) of the
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pencil beams, whose trajectory (the straight line connecting the Bragg peak position to the leaving point at the nozzle)
intersects voxels of such structure. We indicate with {kn} ⊆ {1, · · · , N} the list of indices referring to the subset of pencil
beams crossing the n-th OAR. If the OL = 0, the OAR is considered to be “transparent” and the pencil beams intersecting
the structure are left unaltered, {ω˜kn} = {ωkn}; if the OL = 1, the OAR is completely “opaque” and {ω˜(0)kn } = 0; when
OL = α ∈ (0, 1) is “partially opaque” and the pencil beam fluences are penalized in the following way:
ω˜
(0)
k¯n
= α · lk¯n · ω(0)k¯n ∀k¯n ∈ {kn} , (3)
where lk¯n corresponds to the path length travelled by the k¯n-th pencil beam inside the n-th OAR. Clearly, in this latter
case, the longer the path length inside the OAR, the more the initial fluence of the pencil beam will be decreased. The
three cases are shown in Fig.1.
The OL’s represent essentially an additional degree of freedom at disposal of the planner to change the starting conditions
and, therefore, to steer the outcome of the IMPT optimization. The dose constraints modify ω(0) according to the dose
released by the pencil beam to the OAR, whereas the OL’s acts on the basis of the pencil beam trajectory in relation to
the OAR.
The OL’s penalization requires the knowledge of all the voxel indices that are crossed by every pencil beam. This
computation is efficiently performed by an optimized version of the Siddon algorithm [6], commonly adopted for the fast
calculation of radiological paths.
OAR with OL = 0
Pencil beamsFluence
0
OAR with OL = 1
Pencil beamsFluence
0
OAR with OL    (0,1)  
Pencil beamsFluence
0
Figure 1: Graphical explanation of the opacity penalization, assuming the pencil beams all characterized by the same initial fluence
ω0; on the left, the case of the OAR being “transparent”; in the middle, the case of the OAR being partially “opaque” and penalizing
more the pencil beams travelling more inside the OAR itself; on the right, case of the OAR completely “opaque”.
2 Materials
IMPT plans of different indications and tumour sites have been re-optimized using the OL penalization and the resulting
plans were compared to the delivered ones. In the following, we offer a description of the clinical cases that were selected
for this simulation and of the analysis used to benchmark the robustness of the dose distributions.
2.1 Patient with metallic cage
The first clinical case concerns a patient with an external metallic cage. Patients with neck tumours may undego surgery
before any radiotherapic treatment with protons and a cage is, therefore, required, to stabilize the head to the neck.
Since no calibration curve of the cage material is available for dose calculation, no pencil beam has to cross the metallic
structure to prevent any wrong placement of Bragg peak inside the patient volume.
The strategy followed in the nominal treatment (PLAN-NOM) was to draw safety volumes around the metallic rods and
to apply hard dose constraint to such volumes of interest (VOIs), as shown in Fig.2, such that the pencil beams of the
four fields (F1, F2, F3, F4) involved in the treatment were safe from hitting the rods.
The plan has been re-calculated by replacing the safety VOIs and related dose constraints with the effective contours of
the rods, set with OL = 1. In a first attempt, the direction of the fields were kept the same (PLAN-OL-1) and , then, an
other plan was generated by considering a wider angular spacing between F1-F2 and F3-F4 (PLAN-OL-2). The angular
increase of the new fields with respect to the nominal ones was of 10°.
2.2 Fields crossing nasal cavities
In some clinical cases, the optimal proton fields planned for a treatment cross anatomical cavities to deliver dose to
the target volume. Cavities, like the nose or the bowel, may undergo relevant density changes between the day of the
treatment and the acquisition of the CT image (used to calculate the dose distributions for all the treatment fractions).
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Since the pencil beams crossing the cavity encounter a different density object, they may be affected by not negligible
range uncertanties; in particular, they will undershoot, in case of a density increase, and overshoot, in the opposite
situation.
The case of a treatment with fields crossing the nasal cavity has been taken into consideration. The field directions of
the nominal plan are shown in Fig.3; the frontal fields F1 and F2 encounter the nasal cavity to reach the target volume.
To evaluate the stability of the IMPT plan, first, the original CT image was modified to simulate the extreme scenarios,
of the cavity being completely empty (HU = 0) and filled with mucus (HU ' 30), as shown in Fig.4; the original plan
(PLAN-NOM) and the plan with OL penalization (PLAN-OL), where an OL ∈ (0, 1) was selected for the nose VOI, were
re-computed for both extreme scenarios, to evaluate the potential variation range with respect to the planning CT. We
named PLAN-NOM-H and PLAN-NOM-L, respectively, the difference between the nominal plan recomputed on the CT
with low and high density nasal cavity and the plan computed on the original CT and we did similarly for the extreme
scenario plans with OL penalization (PLAN-OL-H and PLAN-OL-L).
2.3 Head and neck tumour
One common indication for proton therapy centers is represented by tumours extending both in the head and neck. As
the tumour extends over a relatively big area, the treatment can result rather toxic for many organs at risk. These cases
are usually treated with four fields, as shown in Fig.5: two coming from the front, aimed at covering the target volume
at the level of the shoulders, two coming from behind, supposed to deliver the dose in the head part of the tumour. The
drawback of this geometry is that, despite the dose constraints, the front fields irradiate OARs inside the head and, in
the same way, the back fields release high dose to the shoulders, without being crucial for target coverage in that point.
The OL penalization is, here, exploited to switch off the fields in selected areas and to test a new field geometry. In
PLAN-OL-1, two artificial VOIs were drawn at the level if the shoulders and were assigned with OL = 1, to switch off,
respectively, the posterior fields irradiating that area. In PLAN-OL-2, two addional artificial VOIs are created at the
level of the head and set with OL = 1, to switch off the anteriori fields in the part of the patient volume and a fifth
intra-cranial field is added to compensate for the target coverage, as shown in Fig.6.
Figure 2: Patient with metallic cage: nominal IMPT dose distribution; inside the patient volume, the green contour corresponds to
the PTV and the red ones to the OARs; otuside the patient volume, the safety VOIs and the effective countours of the 4 metallic
rods are visible; the fields F1, F2, F3, F4 used for PLAN-NOM and PLAN-OL-1 are also shown.
F1F2
F3 PTV
(a) Axial CT slice
F1 , F2
PTV
(b) Azimuthal CT slice
Figure 3: Fields crossing the nasal cavities: axial and azimuthal CT slice of the nasal cavity plan showing the red contour of the
PTV; the fields F1, F2 and F3 involved in the treatment are also shown.
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(a) Empty nasal cavity (b) Nasal cavity filled with mucus
Figure 4: Fields crossing the nasal cavities: modified CT slices simulating th extreme scenarios, when the nasal cavity is completely
empty (HU=0) and filled with mucus (HU=30).
(a) Empty nasal cavity (b) Nasal cavity filled with mucus
Figure 5: Fields crossing the nasal cavities: axial CT slices with the green contour of the CTV and red contours of some OARs;
the four fields F1, F2, F3, F4 are also indicated.
INTRA−CRANIAL
FIELD
Figure 6: Head and neck tumour: azimuthal CT slice showing the fifth intracranial field added for PLAN-OL-2.
3 Results
The results of the simulations performed with the OL penalization are here shown and compared to the nominal plans,
described in the previous section.
3.1 Patient with metallic cage
Both plans with OL penalization have been re-calculated by dropping the dose constraints on the safety margins drawn
around the metallic rods and by setting the VOIs of the actual rod contours with OL = 1. In this way, all pencil
beams crossing even a voxel of such strutures are completely switched off and they cannot be activated in the subsequent
optimization.
In Fig.7, the dose distributions of PLAN-NOM and PLAN-OL-1 are shown, but it is from tables 1 that we get an insight
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regarding the main differences of the plans. In PLAN-OL-1, the dose coverage of the clinical target volume (CTV)
improves significantly leading to an increase of +5.4% of the volume reached by 100% of the prescribed dose (V100).
Moreover, left and right parotis, the myelon and the brainstem are characterized by a substantial decrease in both the
maximum and the mean dose (Dmax, Dmean) in PLAN-OL-1. The improved sparing of the parotis is well represented
by the comparison of the cumulative DVHs in Fig.8, where the red line refers to PLAN-NOM and the blue one to PLAN-
OL-1.
PLAN-OL-2 was conceived with more angularly spaced fields than the original F1, F2, F3, F4; this configuration would
have been not feasible without the OL penalization, since the tough constraints of the rod safety margins would have
prevented a homogeneous coverage of the target volume, leading necessarily to underdosed areas in the periphery of the
CTV and high dose peaks in the middle. Fig.9 shows the dose distributions of PLAN-NOM and PLAN-OL-2, whereas
results are summarized in tables 2. Despite the fact the increase of V100 is less accentuated in PLAN-OL-2 than in
PLAN-OL-1, the improved target coverage is visible in the comparison of the cumulative DVHs of the CTV in Fig.10,
whereas no difference was noticeable in the cumulative DVH of PLAN-OL-1 compared to PLAN-NOM. This new field
configuration provides a remarkable sparing of the left and right parotis and the brainstem at the cost of decreasing the
improvement concerning the myelon.
(a) PLAN-NOM (b) PLAN-OL-1
Figure 7: Patient with metallic cage: dose distributions for the nominal plan and the one re-computed with OL penalization, keeping
the same field configuration.
(a) Cumulative DVHs of the left parotis
(b) Cumulative DVHs of the right paro-
tis
Figure 8: Patient with metallic cage: comparison between the cumulative DVHs of PLAN-NOM (red line) and PLAN-OL-1 (blue
line) for the left and right parotis.
CTV PTV
Dmean +0.7% +1.2%
V100 +5.4% +7.2%
Dmax Dmean
Right parotis -1.7% -1.1%
Left parotis -3.3% -2.7%
Myelon center -2.5% -0.4%
Brainstem center -1.8% -1.7%
Table 1: Patient with metallica cage: tables summarizing the differences between PLAN-OL-1 and PLAN-NOM concerning the
dose coverage of the target (left table) and OARs (right table).
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(a) PLAN-NOM (b) PLAN-OL-1
Figure 9: Patient with metallic cage: dose distributions for the nominal plan and the one re-computed with OL penalization,
choosing new fields more angularly spaced (+10°) with respect to those used for the nominal plan.
Figure 10: Patient with metallic cage: comparison of the cumulative DVHs of the CTV for PLAN-NOM and PLAN-OL-2.
(a) Cumulative DVHs of the left parotis
(b) Cumulative DVHs of the right paro-
tis
Figure 11: Patient with metallic cage: comparison between the cumulative DVHs of PLAN-NOM (red line) and PLAN-OL-2 (blue
line) for the left and right parotis.
CTV PTV
Dmean +0.9% +1.2%
V100 +1.5% +3.4%
Dmax Dmean
Right parotis -3.4% -2.4%
Left parotis -6.0% -1.4%
Myelon center -1.3% -0.5%
Brainstem center -2.1% -1.8%
Table 2: Patient with metallic cage: tables summarizing the differences between PLAN-OL-2 and PLAN-NOM concerning the dose
coverage of the target (left table) and OARs (right table).
3.2 Fields crossing the nasal cavities
To re-calculate the plan on the original CT with OL penalization, the VOI of the nasal cavity was drawn and set with
an OL = 0.5, meaning that pencil beams were decreased in fluence proportionally to their path length inside the VOI,
according to formula (3). In the nominal plan, no dose constraints or other countermeasures were taken into consideration
to deal with the potential density changes of the nasal cavities, since they lie close to the target volume and any dose
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CTV
Dmean +0.4%
V100 +3.1%
CTV
Dmean +0.5%
V100 +5.3%
Table 3: Fields crossing the nasal cavities: tables summarizing the differences between PLAN-OL-H and PLAN-NOM-H (on the
left) and PLAN-OL-L and PLAN-NOM-L (on the right) concerning the dose coverage of the target.
constraint would severely affect the target coverage.
Fig.12 shows the dose distribution of PLAN-NOM and PLAN-OL, that were computed on the original CT. The plans
result to be identical up to differences of 0.2%, as far as concerns both the target coverage and the sparing of the OARs.
When PLAN-NOM and PLAN-OL are re-computed on the extreme scenario CTs of Fig.4 and the difference between
each of these extreme-case plan and the corresponding reference ones are considered, interesting results emerge. Fig.12
shows PLAN-NOM-H and PLAN-OL-H, whereas tables 3 highlights the fact that in both scenarios the target coverage
is more remarkably more robust for PLAN-OL than for PLAN-NOM, since V100 improves by 3.1% in the high-density
nose cavities case and by +5.3% in the other one.
(a) PLAN-NOM (b) PLAN-OL
Figure 12: Fields crossing the nasal cavities: dose distributions for the nominal plan and the one re-computed with OL penalization
for the nasal cavity case.
(a) PLAN-NOM-H (b) PLAN-OL-H
Figure 13: Fields crossing the nasal cavities: difference between the dose distribution re-calculated on the CT with nasal cavities
filled with mucus and the one computed on the original CT, for the nominal plan and the one re-computed with OL penalization.
3.3 Head and neck tumour
In this clinical case, the OL penalization is aimed at optimizing the same fields of the nominal plan (PLAN-OL-1) and
at testing a new treatment configuration (PLAN-OL-2).
By comparing the dose distributions of PLAN-NOM and PLAN-OL-1 at the level of the shoulders in Fig.14, it is noticeable
how the dose in PLAN-OL-1 results better confined inside the CTV. This fact determines a remarkable improvement in
the sparing of the esophagus and the spinal cord, as reported in Table 4 and in Fig.15, where the comparison between
the cumulative DVHs of the two plans are shown. No relevant changes concern the coverage of the target volume, since
Dmean differs by 0.3% from the nominal plan. These results clearly show that switching off the posterior fields at the
level of the shoulders allows to achieve a better sparing of some OARs, while keeping the same irradiation level for the
tumour.
In PLAN-OL-2, a different field geometry has been investigated: the posterior fields are switched off at the level of the
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(a) PLAN-NOM (b) PLAN-OL-1
Figure 14: Head and neck tumour: dose distributions of PLAN-NOM and PLAN-OL-1 at the level of the shoulders.
(a) Esophagus (b) Spinal cord
Figure 15: Head and neck tumour: comparison between the cumulative DVHs of PLAN-NOM (red line) and PLAN-OL-1 (blue
line) for the esophagus and the spinal cord.
Dmax Dmean
Right inner ear -0.3% -1.2%
Esophagus / -2.2%
Spinal cord -0.2% -3.2%
Brainstem -1.0% -0.6%
Table 4: Head and neck tumour: tables summarizing the differences between PLAN-OL-1 and PLAN-NOM concerning the the
sparing of the OARs.
shoulders, the anterior ones at the level of the head and a fifth intracranial field is added (Fig.6). The goal was to achieve
a better preservation of the OARs inside the head. The dose distributions (Fig.16) share a very similar coverage of the
target volume, but they are characterized by substantial differences in the dose delivered to the OARs, as shown by Table
5. In fact, the huge improvements in the sparing of the chiasm, right lens (Fig.17a), left lens (17b), left inner ear and the
spinal cord (considering in first place the decrease of Dmax) are followed by a significant increase of the peak dose inside
the thyroid and the mean dose to the brainstem. In this case, PLAN-OL-2 is not necessarily superior to PLAN-NOM,
but it is undeniable that the OL penalization has allowed the planner to test a scenario, that the simple enforcement of
the dose constraints would not have provided.
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(a) Esophagus (b) Spinal cord
Figure 16: Head and neck tumour: dose distributions of PLAN-NOM and PLAN-OL-2 at the level of the head.
(a) Left lense (b) Right lense
(c) Right optical nerve
Figure 17: Head and neck tumour: comparison between the cumulative DVHs of PLAN-NOM (red line) and PLAN-OL-2 (blue
line) for the left and right lense and the right optical nerve.
Dmax Dmean
Right lens -9.0% -7.1%
Left lens -3.9% -4.1%
Left inner ear -2.6% +0.3%
Left parotis gland -0.2% -3.9%
Thyroid +2.7% +4.9%
Spinal cord -2.0% +2.0%
Brainstem -1.9% +9.5%
Chiasm -13.9% -4.3%
Table 5: Head and neck tumour: tables summarizing the differences between PLAN-OL-2 and PLAN-NOM concerning the the
sparing of the OARs.
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4 Discussion
In this work, we have introduced the concept of opacity as a quality assigned to VOIs and aimed at steering the outcome
of the IMPT planning by changing the starting condition of the optimization. In particular, the opacity level (OL) of a
VOI is a weight ranging in [0,1] and is used to penalize the initial fluence of the pencil beams crossing the voxels of such
structure: when OL = 0, the VOI is transparent and no penalization is performed; when 0 < OL < 1, the pencil beams
are decreased in fluence proportionally to their path length inside the VOI; when OL = 1, they are totally switched off.
We have shown how this simple additional feature can lead to dose distributions of higher quality and robustness within
the framework the IMPT treatment planning. Three different clinical cases were taken into consideration to show the
potential advantage of adopting the OL penalization in the pre-optimization stage: a patient with a post-surgery metallic
cage, a treatment where fields cross the nasal cavities and the case of a complex head and neck tumour.
Concerning the first clinical case, the opacity tool has shown to perfectly tackle the presence of metallic structures: the
safety margins and hard dose constraint on the metal are replaced with the actual contour of the structure and set with
OL = 1. This approach has lead to a plan, where both the coverage of the target volume and the sparing of some OARs
have improved. The strategy to handle the metallic cage can be re-proposed for golden teeth or any other prothesis,
whose composition and, therefore, calibration curve are not known.
As far as regards the second clinical case, the OL penalization has provided a more robust dose distribution in relation
to the possible density changes inside the nasal cavities. Since the the plan does not change when OL is set to a specific
value in (0,1), we obtain a simple way to guarantee the stability of the treatment. This approach may be applied for
any other anatomical cavity, placed close to the tumour and that can undergo substantial density variations within the
treatment frametime.
For the case of the head and neck tumour, we have shown how the opacity allows to optimize the usage of each single
field, especially when dealing with a tumour mass of complex shape and considerable extension. We have also pointed
out how the opacity can easily shape the fields in order to test treatment scenario, that would not be possible to achieve
only through dose constraints.
In conclusion, the opacity is a leverage that be used by the planner to mould the IMPT dose distributions, when seeking
for the best tradeoff between target coverage and sparing of the OARs. It is no meant to replace the dose constraints,
but rather to be played as an additional card in the IMPT treatment planning.
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